BDBM63598 2-(3-keto-2,4-dihydro-1H-quinoxalin-2-yl)-N-[2-[[2-(3-keto-2,4-dihydro-1H-quinoxalin-2-yl)acetyl]amino]phenyl]acetamide::2-(3-oxidanylidene-2,4-dihydro-1H-quinoxalin-2-yl)-N-[2-[2-(3-oxidanylidene-2,4-dihydro-1H-quinoxalin-2-yl)ethanoylamino]phenyl]ethanamide::2-(3-oxo-2,4-dihydro-1H-quinoxalin-2-yl)-N-[2-[[1-oxo-2-(3-oxo-2,4-dihydro-1H-quinoxalin-2-yl)ethyl]amino]phenyl]acetamide::2-(3-oxo-2,4-dihydro-1H-quinoxalin-2-yl)-N-[2-[[2-(3-oxo-2,4-dihydro-1H-quinoxalin-2-yl)acetyl]amino]phenyl]acetamide::MLS000709408::SMR000290075::cid_2876301
SMILES Cc1ccccc1-n1[nH]c(=O)c2cccc(NC(=O)c3coc4c(F)cc(Cl)cc34)c21
InChI Key InChIKey=AGKLWEWOQZWBIZ-UHFFFAOYSA-N
Data 1 EC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 63598
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Relay Therapeutics
US Patent
Relay Therapeutics
US Patent
Affinity DataIC50: 300nMAssay Description:HeLa cells were obtained from the American Type Culture Collection (ATCC) and maintained in DMEM media containing 10% FBS. Cells (7,000/well) were se...More data for this Ligand-Target Pair
